S. 1780Senate108th Congress (2003-2005)In Committee

Anabolic Steroid Control Act of 2003

Introduced October 23, 2003

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S13141)

October 23, 2003

View full timeline
SenateIntro Referral

Introduced in Senate

October 23, 2003

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S13139-13141)

October 23, 2003

SenateIntro Referral

Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S13141)

October 23, 2003

Floor Debate

22 members

What members said about S. 1780 on the floor

9 Republicans13 Democrats
Robert F. Bennett
Sen. Robert F. BennettR-UT · Nov 5, 2003

Mr. President, it is our intention to move next to the amendment of the Senator from Hawaii, Mr. Akaka; and, after that, to the amendment of Senator Cantwell. However, Senator Specter from…

Joseph R. Biden Jr.
Sen. Joseph R. Biden Jr.D-DE · Oct 23, 2003

Mr. President, I rise tonight to introduce, along with my good friend from Utah, Senator Hatch, the distinguished Chairman of the Judiciary Committee, the ``Anabolic Steroid Control Act of 2003.''…

Joseph R. Biden Jr.
Sen. Joseph R. Biden Jr.D-DE · Oct 23, 2003

Mr. President, I rise tonight to introduce, along with my good friend from Utah, Senator Hatch, the distinguished Chairman of the Judiciary Committee, the ``Anabolic Steroid Control Act of 2003.''…

Richard J. Durbin
Sen. Richard J. DurbinD-IL · Nov 5, 2003

Mr. President, I ask unanimous consent that the order for the quorum call be rescinded. I ask the chairman if this is an appropriate time for me to make a 10- or 15-minute statement relative to an…

Maria Cantwell
Sen. Maria CantwellD-WA · Nov 5, 2003

Mr. President, I call up my amendment and I send it to the desk. Mr. President, I ask unanimous consent that reading of the amendment be dispensed with. I ask unanimous consent that Senators…

Show 8 more
Paul S. Sarbanes
Sen. Paul S. SarbanesD-MD · Oct 23, 2003

Mr. President, I am pleased to introduce the Federal Employee Commuter Benefits Act of 2003, which is cosponsored by my colleagues Senators Mikulski, Warner, and Allen. This bill will guarantee…

Orrin G. Hatch
Sen. Orrin G. HatchR-UT · Nov 5, 2003

Mr. President, I thank the managers, Chairman Bennett and Senator Kohl, for agreeing to the amendment that Senators Harkin, Durbin and I offer today. The purpose of our amendment is simple. The Food…

Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Oct 23, 2003

Mr. President, I rise today to introduce the ``Methamphetamine Blister Pack Loophole Elimination Act of 2003,'' along with my colleagues Senators Grassley, Kohl, Biden, Kyl and Harkin. This is a…

Jeff Bingaman
Sen. Jeff BingamanD-NM · Oct 23, 2003

Mr. President, I am introducing today the Medicare Indian Health Fairness Act of 2003 with Senators Inouye, Daschle, Murray, Dayton, Johnson, Cantwell, and Stabenow. This legislation would take a…

Ben Nelson
Sen. Ben NelsonD-NE · Nov 5, 2003

Madam President, thank you very much for this opportunity to speak on an issue important not only to my State but also to other States in my country as it continues to plague agricultural producers…

Chuck Grassley
Sen. Chuck GrassleyR-IA · Oct 23, 2003

Mr. President, I am pleased to join Senator Biden and Senator Hatch as a co-sponsor of the Steroid Control Act of 2003. Our youth need to understand that while the short-term use of steroids may seem…

Lisa Murkowski
Sen. Lisa MurkowskiR-AK · Oct 23, 2003

Mr. President, today I introduce along with my colleague, Senator Stevens, an important bill that will facilitate Forest Service land management on Prince of Wales Island and help community expansion…

Daniel K. Akaka
Sen. Daniel K. AkakaD-HI · Nov 5, 2003

Mr. President, I rise today to offer an amendment to H.R. 2673, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for fiscal year 2004, that…

Show 11 more
Mark Dayton
Sen. Mark DaytonD-MN · Nov 5, 2003

Mr. President, responding to the distinguished manager of the bill, I myself will take less than 10 minutes. It is my understanding there may be one or two other Senators who wish to speak on this…

Susan M. Collins
Sen. Susan M. CollinsR-ME · Nov 5, 2003

Mr. President, I am pleased to join my colleague, Senator Olympia Snowe, in offering an amendment that will expand the borders of the Aroostook County Empowerment Zone to include the entire county,…

Olympia J. Snowe
Sen. Olympia J. SnoweR-ME · Nov 5, 2003

Mr. President, I rise today to engage in a colloquy with the distinguished chairman of the Agriculture Appropriations Subcommittee. As the chairman of this subcommittee, my good friend from Utah is…

Ben Nighthorse Campbell
Sen. Ben Nighthorse CampbellR-CO · Oct 23, 2003

Mr. President, today I am introducing the Intermodal Equipment Safety and Responsibility Act of 2003. This bill is a companion bill to language originally brought to the floor of the House of…

Max Baucus
Sen. Max BaucusD-MT · Nov 5, 2003

Mr. President, I would like to thank Senator Dayton for offering this amendment to secure emergency agricultural disaster assistance for our drought stricken agricultural producers. I worked the past…

Thad Cochran
Sen. Thad CochranR-MS · Nov 5, 2003

Mr. President, I would like to thank my distinguished colleague, the chairman of the Appropriations Subcommittee on Agriculture, Rural Development and Related Agencies, Senator Bennett, for his…

Byron L. Dorgan
Sen. Byron L. DorganD-ND · Nov 5, 2003

I wonder if the Senator from Utah will yield for a question. I am not certain exactly what the status of the bill is. I know we have been working on it all day. My understanding is that we have had…

Chuck Grassley
Sen. Chuck GrassleyR-IA · Oct 23, 2003

Mr. President, I am pleased to join Senator Biden and Senator Hatch as a co-sponsor of the Steroid Control Act of 2003. Our youth need to understand that while the short-term use of steroids may seem…

John F. Kerry
Sen. John F. KerryD-MA · Oct 23, 2003

Mr. President, I rise to introduce legislation that is designed to eliminate tariffs on certain tuna products imported into the United States from member nations of the Association of Southeast Asian…

Conrad R. Burns
Sen. Conrad R. BurnsR-MT · Nov 5, 2003

Mr. President, the Farm Security and Rural Investment Act of 2002 added new a new provision of the Rural Electrification Act giving the Rural Utilities Service, (RUS), Administrator the authority to…

Thomas A. Daschle
Sen. Thomas A. DaschleD-SD · Nov 5, 2003

Mr. President, today Senator Frist and I are offering an amendment to authorize a new program that we call the Sun Grant Initiative. The Sun Grant Initiative--or SGI--is an effort to provide an…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued October 23, 2003
        [Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 1780 Introduced in Senate (IS)]

108th CONGRESS
1st Session
S. 1780

To amend the Controlled Substances Act to clarify the definition of
anabolic steroids and to provide for research and education activities
relating to steroids and steroid precursors.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

October 23, 2003

Mr. Biden (for himself, Mr. Hatch, Mr. Grassley, and Mr. Harkin)
introduced the following bill; which was read twice and referred to the
Committee on the Judiciary

_______________________________________________________________________

A BILL

To amend the Controlled Substances Act to clarify the definition of
anabolic steroids and to provide for research and education activities
relating to steroids and steroid precursors.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Anabolic Steroid Control Act of
2003''.

SEC. 2. AMENDMENTS TO THE CONTROLLED SUBSTANCES ACT.

(a) Definitions.--Section 102 of the Controlled Substances Act (21
U.S.C. 802) is amended--
(1) in paragraph (41)--
(A) by realigning the margin so as to align with
paragraph (40);
(B) by striking subparagraph (A) and inserting the
following:
``(A) The term `anabolic steroid' means any drug or hormonal
substance, chemically and pharmacologically related to testosterone
(other than estrogens, progestins, corticosteroids, and
dehydroepiandrosterone), and includes--
``(i) androstanediol--
``(I) 3b,17b-dihydroxy-5a-androstane; and
``(II) 3a,17b-dihydroxy-5a-androstane;
``(ii) androstanedione (5a-androstan-3,17-dione);
``(iii) androstenediol--
``(I) 1-androstenediol (3b,17b-dihydroxy-5a-
androst-1-ene);
``(II) 1-androstenediol (3a,17b-dihydroxy-5a-
androst-1-ene);
``(III) 4-androstenediol (3b,17b-dihydroxy-androst-
4-ene); and
``(IV) 5-androstenediol (3b,17b-dihydroxy-androst-
5-ene);
``(iv) androstenedione--
``(I) 1-androstenedione ([5a]-androst-1-en-3,17-
dione);
``(II) 4-androstenedione (androst-4-en-3,17-dione);
and
``(III) 5-androstenedione (androst-5-en-3,17-
dione);
``(v) bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-
3-one);
``(vi) boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
``(vii) calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-
en-3-one);
``(viii) clostebol (4-chloro-17b-hydroxyandrost-4-en-3-
one);
``(ix) dehydrochlormethyltestosterone (4-chloro-17b-
hydroxy-17a-methyl-androst-1,4-dien-3-one);
``(x) 4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
``(xi) drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-
one);
``(xii) ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
``(xiii) fluoxymesterone (9-fluoro-17a-methyl-11b,17b-
dihydroxyandrost-4-en-3-one);
``(xiv) formebolone (2-formyl-17a-methyl-11a,17b-
dihydroxyandrost-1,4-dien-3-one);
``(xv) furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-
furazan);
``(xvi) 18a-homo-17b-hydroxyestr-4-en-3-one (13b-ethyl-17b-
hydroxygon-4-en-3-one);
``(xvii) 4-hydroxytestosterone (4,17b-dihydroxy-androst-4-
en-3-one);
``(xviii) 4-hydroxy-19-nortestosterone (4,17b-dihydroxy-
estr-4-en-3-one);
``(xix) mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-
one);
``(xx) mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-3-
one);
``(xxi) methandienone (17a-methyl-17b-hydroxyandrost-1,4-
dien-3-one);
``(xxii) methandriol (17a-methyl-3b,17b-dihydroxyandrost-5-
ene);
``(xxiii) methenolone (1-methyl-17b-hydroxy-5a-androst-1-
en-3-one);
``(xxiv) methyltestosterone (17a-methyl-17b-hydroxyandrost-
4-en-3-one);
``(xxv) mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-3-
one);
``(xxvi) nandrolone (17b-hydroxyestr-4-en-3-one);
``(xxvii) norandrostenediol--
``(I) 19-nor-4-androstenediol (3b, 17b-
dihydroxyestr-4-ene);
``(II) 19-nor-4-androstenediol (3a, 17b-
dihydroxyestr-4-ene);
``(III) 19-nor-5-androstenediol (3b, 17b-
dihydroxyestr-5-ene); and
``(IV) 19-nor-5-androstenediol (3a, 17b-
dihydroxyestr-5-ene);
``(xxviii) norandrostenedione--
``(I) 19-nor-4-androstenedione (estr-4-en-3,17-
dione); and
``(II) 19-nor-5-androstenedione (estr-5-en-3,17-
dione;
``(xxix) norbolethone (18a-homo-17b-hydroxypregna-4-en-3-
one);
``(xxx) norclostebol (4-chloro-17b-hydroxyestr-4-en-3-one);
``(xxxi) norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-3-
one);
``(xxxii) oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-
androstan-3-one);
``(xxxiii) oxymesterone (17a-methyl-4,17b-dihydroxyandrost-
4-en-3-one);
``(xxxiv) oxymetholone (17a-methyl-2-hydroxymethylene-17b-
hydroxy-[5a]-androstan-3-one);
``(xxxv) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-
eno[3,2-c]-pyrazole);
``(xxxvi) stenbolone (17b-hydroxy-2-methyl-[5a]-androst-1-
en-3-one);
``(xxxvii) testolactone (13-hydroxy-3-oxo-13,17-
secoandrosta-1,4-dien-17-oic acid lactone);
``(xxxviii) 1-testosterone (17b-hydroxy-5a-androst-1-en-3-
one);
``(xxxix) testosterone (17b-hydroxyandrost-4-en-3-one);
``(xl) tetrahydrogestrinone (13b,17a-diethyl-17b-
hydroxygon-4,9,11-trien-3-one);
``(xli) trenbolone (17b-hydroxyestr-4,9,11-trien-3-one);
and
``(xlii) any salt, ester, or ether of a drug or substance
described in this paragraph.''; and
(C) by adding at the end the following:
``(C) Notwithstanding subparagraph (A), the Attorney General may
not schedule Androstenedione as a controlled substance in accordance
with this Act until the Attorney General receives a finding from the
Commissioner of Food and Drugs relating to whether Androstenedione is
lawfully marketed under the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 321 et seq.).''; and
(2) in paragraph (44), by inserting ``anabolic steroids,''
after ``marihuana,''.
(b) Authority and Criteria for Classification.--Section 201(g) of
the Controlled Substances Act (21 U.S.C. 811(g)) is amended--
(1) in paragraph (1), by striking ``substance from a
schedule if such substance'' and inserting ``drug which
contains a controlled substance from the application of titles
II and III of the Comprehensive Drug Abuse Prevention and
Control Act (21 U.S.C. 802 et seq.) if such drug''; and
(2) in paragraph (3), by adding at the end the following:
``(C) Upon the recommendation of the Secretary of Health
and Human Services, a compound, mixture, or preparation which
contains any anabolic steroid, which is intended for
administration to a human being or an animal, and which,
because of its concentration, preparation, formulation or
delivery system, does not present any significant potential for
abuse.''.
(c) Anabolic Steroids Control Act.--Section 1903 of the Anabolic
Steroids Control Act of 1990 (Public Law 101-647) is amended--
(1) by striking subsection (a); and
(2) by redesignating subsections (b) and (c) as subsections
(a) and (b), respectively.

SEC. 3. SENTENCING COMMISSION GUIDELINES.

The United States Sentencing Commission shall--
(1) review the Federal sentencing guidelines with respect
to offenses involving anabolic steroids;
(2) consider amending the Federal sentencing guidelines to
provide for increased penalties with respect to offenses
involving anabolic steroids in a manner that reflects the
seriousness of such offenses and the need to deter anabolic
steroid use; and
(3) take such other action that the Commission considers
necessary to carry out this section.

SEC. 4. PREVENTION AND EDUCATION PROGRAMS.

(a) In General.--The Secretary of Health and Human Services
(referred to in this Act as the ``Secretary'') shall award grants to
public and nonprofit private entities to enable such entities to carry
out science-based education programs in elementary and secondary
schools to highlight the harmful effects of anabolic steroids.
(b) Eligibility.--
(1) Application.--To be eligible for grants under
subsection (a), an entity shall prepare and submit to the
Secretary an application at such time, in such manner, and
containing such information as the Secretary may require.
(2) Preference.--In awarding grants under subsection (a),
the Secretary shall give preference to applicants that intend
to use grant funds to carry out programs based on--
(A) the Athletes Training and Learning to Avoid
Steroids program;
(B) the Athletes Targeting Healthy Exercise and
Nutrition Alternatives program; and
(C) other programs determined to be effective by
the National Institute on Drug Abuse.
(c) Use of Funds.--Amounts received under a grant under subsection
(a) shall be used primarily for education programs that will directly
communicate with teachers, principals, coaches, as well as elementary
and secondary school children concerning the harmful effects of
anabolic steroids.
(d) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section, $15,000,000 for each of fiscal
years 2004 through 2009.

SEC. 5. NATIONAL SURVEY ON DRUG USE AND HEALTH.

(a) In General.--The Secretary of Health and Human Services shall
ensure that the National Survey on Drug Use and Health includes
questions concerning the use of anabolic steroids.
(b) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section, $1,000,000 for each of fiscal
years 2004 through 2009.
<all>